Medicinova (MNOV) Other Accumulated Expenses (2012 - 2025)
Medicinova's (MNOV) quarterly Other Accumulated Expenses came in at $146540.0 in Q4 2025, up 15.54% year-on-year from $126832.0 in Q4 2024, and up 15.54% on a QoQ basis from $126832.0 in Q4 2024.
Medicinova (MNOV) Other Accumulated Expenses (2012 - 2025) Analysis & Trends
Medicinova (MNOV) has 14 years of Other Accumulated Expenses data on file, last reported at $146540.0 in Q4 2025.
- On a quarterly basis, Other Accumulated Expenses rose 15.54% year-over-year to $146540.0 in Q4 2025; TTM through Dec 2025 was $146540.0, a 15.54% increase from a year earlier, with the FY2025 full-year figure at $146540.0, up 15.54% from the prior year.
- Other Accumulated Expenses for Q4 2025 stood at $146540.0, up from $126832.0 in the prior quarter.
- Over the last five years, Other Accumulated Expenses for MNOV reached as high as $547270.0 in Q4 2021 and fell as low as $126832.0 in Q4 2024.
- Historically, Other Accumulated Expenses has averaged $233823.4 across 5 years, with a median of $164375.0 in 2023.
- Across the five-year window, Other Accumulated Expenses soared 441.62% in 2021 and tumbled 66.36% in 2022, its largest moves.
- Year by year, Other Accumulated Expenses stood at $547270.0 in 2021, then tumbled by 66.36% to $184100.0 in 2022, then retreated by 10.71% to $164375.0 in 2023, then slipped by 22.84% to $126832.0 in 2024, then gained by 15.54% to $146540.0 in 2025.
- Per Business Quant data, the three most recent Other Accumulated Expenses figures were $146540.0 in Q4 2025, $126832.0 in Q4 2024, and $164375.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Medicinova | 64.76 Mn | 64.76 Mn | 4,754.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 146,540.00 |
| Dec 31, 2024 | 126,832.00 |
| Dec 31, 2023 | 164,375.00 |
| Dec 31, 2022 | 184,100.00 |
| Dec 31, 2021 | 547,270.00 |
| Dec 31, 2020 | 101,043.00 |
| Dec 31, 2019 | 354,707.00 |
| Dec 31, 2018 | 191,932.00 |
| Dec 31, 2017 | 141,504.00 |
| Dec 31, 2016 | 145,600.00 |
| Dec 31, 2015 | 158,559.00 |
| Dec 31, 2014 | 127,643.00 |
| Dec 31, 2013 | 102,094.00 |
| Sep 30, 2013 | 171,031.00 |
| Jun 30, 2013 | 169,372.00 |
| Dec 31, 2012 | 94,504.00 |